It has also completed the USFDA's surveillance inspection at Jeedimetla  Hyderabad  unit. The pharmaceutical company has completed the US Food and Drug Administration s  USFDA  Pre-Approval Inspection  PAI  and GMP audit for their facility  Unit IV  at Visakhapatnam in Andhra Pradesh.
The pharmaceutical company has completed the USFDA's surveillance inspection at Jeedimetla Hyderabad unit and Pre-Approval Inspection and GMP audit for their facility Unit IV at Visakhapatnam in Andhra Pradesh.